Novo Nordisk A/S (NVO) stock prices updated...
 

Novo Nordisk A/S stock price

Novo Nordisk A/S latest news:


  • 08/16/2017 15:31:19

    Novo Nordisk's diabetes drug succeeds in key trial

    Aug 16 (Reuters) - Novo Nordisk A/S said on Wednesday its diabetes drug met the main goal of reducing glucose levels in patients in a key late-stage trial, setting the stage for it to become the new standard therapy for type 2 diabetes.

  • More trends:

    NOW Inc.DNOW | NQ Mobile Inc.NQ | NRG EnergyNRG | NRG YieldNYLD | NRG YieldNYLD.A | NTT DOCOMODCM | Nu Skin EnterprisesNUS | Nucor CorporationNUE | Nustar Energy L.P.NS | Nustar GP HoldingsNSH |